These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 33785338

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C, Shan Z, Hong J, Yang L.
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [Abstract] [Full Text] [Related]

  • 3. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.
    Zhu HE, Yin JY, Chen DX, He S, Chen H.
    Cell Death Dis; 2019 Nov 07; 10(11):854. PubMed ID: 31699997
    [Abstract] [Full Text] [Related]

  • 4. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
    Gao Y, Luo L, Xie Y, Zhao Y, Yao J, Liu X.
    Mol Carcinog; 2020 May 07; 59(5):503-511. PubMed ID: 32133692
    [Abstract] [Full Text] [Related]

  • 5. Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway.
    Zhu B, Wei Y.
    Cancer Med; 2020 Jan 07; 9(2):783-796. PubMed ID: 31957323
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
    Liang J, Li H, Han J, Jiang J, Wang J, Li Y, Feng Z, Zhao R, Sun Z, Lv B, Tian H.
    Cell Death Dis; 2020 Aug 13; 11(8):614. PubMed ID: 32792503
    [Abstract] [Full Text] [Related]

  • 8. GALNT2/14 overexpression correlate with prognosis and methylation: potential therapeutic targets for lung adenocarcinoma.
    Yu Y, Wang Z, Zheng Q, Li J.
    Gene; 2021 Jul 20; 790():145689. PubMed ID: 33964375
    [Abstract] [Full Text] [Related]

  • 9. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
    Feng H, Zhang Z, Qing X, French SW, Liu D.
    Exp Mol Pathol; 2019 Jun 20; 108():105-113. PubMed ID: 30981721
    [Abstract] [Full Text] [Related]

  • 10. Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis.
    Sun D, Zhu Y, Zhao H, Bian T, Li T, Liu K, Feng L, Li H, Hou H.
    Cell Oncol (Dordr); 2021 Oct 20; 44(5):1019-1034. PubMed ID: 34109546
    [Abstract] [Full Text] [Related]

  • 11. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
    Ma S, Wang X, Zhang Z, Liu D.
    Thorac Cancer; 2020 Mar 20; 11(3):526-536. PubMed ID: 31962007
    [Abstract] [Full Text] [Related]

  • 12. CAPN1 promotes malignant behavior and erlotinib resistance mediated by phosphorylation of c-Met and PIK3R2 via degrading PTPN1 in lung adenocarcinoma.
    Chen Y, Tang J, Lu T, Liu F.
    Thorac Cancer; 2020 Jul 20; 11(7):1848-1860. PubMed ID: 32395869
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K, Zhang T, Fan Y, Serick, Du G, Wu P, Geng D.
    Tumour Biol; 2016 Oct 20; 37(10):13469-13477. PubMed ID: 27465551
    [Abstract] [Full Text] [Related]

  • 14. DUS4L suppresses invasion and metastasis in LUAD via modulation of PI3K/AKT and ERK/MAPK signaling through GRB2.
    Li Z, Zhao PL, Gao X, Li X, Meng YQ, Li ZQ, Zhai KR, Wei SL, Feng HM, Huang HR, Li B.
    Int Immunopharmacol; 2024 Dec 05; 142(Pt A):113043. PubMed ID: 39216120
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of FYN suppresses the epithelial-to-mesenchymal transition through down-regulating PI3K/AKT pathway in lung adenocarcinoma.
    Xue F, Jia Y, Zhao J.
    Surg Oncol; 2020 Jun 05; 33():108-117. PubMed ID: 32561075
    [Abstract] [Full Text] [Related]

  • 16. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C, Dong X, Lu H, Tong F, Chen L, Zhang R, Dong J, Hu Y, Wu G, Dong X.
    J Exp Clin Cancer Res; 2019 Feb 21; 38(1):95. PubMed ID: 30791942
    [Abstract] [Full Text] [Related]

  • 17. Targeting PRMT5/Akt signalling axis prevents human lung cancer cell growth.
    Zhang S, Ma Y, Hu X, Zheng Y, Chen X.
    J Cell Mol Med; 2019 Feb 21; 23(2):1333-1342. PubMed ID: 30461193
    [Abstract] [Full Text] [Related]

  • 18. IGF2BP3 aggravates lung adenocarcinoma progression by modulation of PI3K/AKT signaling pathway.
    Chen X, Zhu X, Shen X, Liu Y, Fu W, Wang B.
    Immunopharmacol Immunotoxicol; 2023 Jun 21; 45(3):370-377. PubMed ID: 36972188
    [Abstract] [Full Text] [Related]

  • 19. MiR-340-3p-HUS1 axis suppresses proliferation and migration in lung adenocarcinoma cells.
    Ren K, Yu Y, Wang X, Liu H, Zhao J.
    Life Sci; 2021 Jun 01; 274():119330. PubMed ID: 33711383
    [Abstract] [Full Text] [Related]

  • 20. Upregulation of sine oculis homeobox homolog 3 is associated with proliferation, invasion, migration, as well as poor prognosis of esophageal cancer.
    Du J.
    Anticancer Drugs; 2019 Jul 01; 30(6):596-603. PubMed ID: 30672777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.